ARTICLE | Distillery Therapeutics
Therapeutics: Fibronectin type III domain containing 5 (FNDC5; irisin)
October 15, 2015 7:00 AM UTC
Mouse studies suggest the skeletal muscle-derived myokine FNDC5 could help treat osteoporosis and other forms of bone loss. In normal mice, injection of human-mouse chimeric FNDC5 increased cortical b...